Improving the therapeutic ratio in head and neck cancer

Lancet Oncol. 2010 Jun;11(6):512-3. doi: 10.1016/S1470-2045(10)70060-7.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / radiotherapy*
  • Carcinoma, Squamous Cell / virology
  • Head and Neck Neoplasms / metabolism
  • Head and Neck Neoplasms / radiotherapy*
  • Head and Neck Neoplasms / virology
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / analysis
  • Precision Medicine
  • Prognosis

Substances

  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit